Data / Form D filings / HEMOBIOTECH, INC.
HEMOBIOTECH, INC.: Form D filings
HEMOBIOTECH, INC., a pharmaceuticals company in Dallas, TX, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on January 25, 2010, reports an offering of $3.5 million with nothing sold yet.
Find out what HEMOBIOTECH, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5001 SPRING VALLEY ROAD, SUITE 1040 - WEST, Dallas, TX, 75244
- Phone
- (972) 455-8950
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1301348
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 25, 2010 | New notice | $3,500,000 | $0 | $3,500,000 | 0 | Yet to occur | sec.gov |
| Nov 4, 2009 | New notice | $350,000 | $160,000 | $190,000 | 5 | Oct 14, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Comer | Executive Officer, Director | |
| Bernhard Mittemeyer | Director | |
| Ghassan Nino | Director | |
| Robert Baron | Director | |
| Robert Dragoo, Jr. | Director | |
| Arthur Bollon | Executive Officer, Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Jan 25, 2010 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what HEMOBIOTECH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.